resveratrol has been researched along with Neurodegenerative Diseases in 77 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (10.39) | 29.6817 |
| 2010's | 45 (58.44) | 24.3611 |
| 2020's | 24 (31.17) | 2.80 |
| Authors | Studies |
|---|---|
| Adán, N; Belmonte-Reche, E; Caro, M; Delgado, M; González-Rey, E; Mateos-Martín, ML; Morales, JC; Peñalver, P | 1 |
| Chen, Y; Feng, F; Li, Q; Liu, W; Liu, Y; Sun, H; Xing, S | 1 |
| Amoroso, R; Carradori, S; De Filippis, B; Fantacuzzi, M | 1 |
| Calazans, MO; De Oliveira, ACP; Ribeiro, R; Santos, AC; Vieira, LB | 1 |
| Campos, TG; Damasio, CM; de Freitas Silva, M; Dos Reis Rosa Franco, G; Ernesto, JT; Gontijo, VS; Ortiz, CJC; Silva, IMF; Viegas, C; Viegas, FPD | 1 |
| André-Miral, C; Arbo, BD; Dos Santos, MG; Hort, MA; Muccillo-Baisch, AL; Schimith, LE | 1 |
| Çinar, R; Naziroğlu, M; Yildizhan, K | 1 |
| Chen, L; Li, Q; Li, X; Tian, B | 1 |
| Akter, A; Alhumaydhi, FA; Baghayeri, M; Eftekhari, A; Emran, TB; Islam, F; Islam, MM; Islam, MR; Karimi, F; Khan Meem, AF; Khusro, A; Mitra, S; Nafady, MH; Simal-Gandara, J | 1 |
| Elyasi, L; Jahanshahi, M; Jesmi, F; Rosenholm, JM | 1 |
| Ahmad, SMS; Al-Mansoob, M; Eid, AH; Giordo, R; Haider, MZ; Pintus, G; Posadino, AM; Shaito, A | 1 |
| Nguyen, HD | 1 |
| Agamennone, M; Ammazzalorso, A; Angeli, A; Carradori, S; De Filippis, B; Fantacuzzi, M; Galati, S; Petzer, A; Petzer, JP; Poli, G; Supuran, CT; Tuccinardi, T | 1 |
| Tang, Z; Zhang, M | 1 |
| Huo, X; Liu, H; Wang, S; Yin, S; Yin, Z | 1 |
| Hassan, MI; Islam, A; Khan, S; Shahid, M | 1 |
| Gulyayev, A; Krivykh, E; Masoud, AR; Nurgozhin, T; Saliev, T; Sergazy, S; Umbayev, B; Yessenkyzy, A; Zhanaliyeva, M | 1 |
| Komorowska, J; Szukiewicz, D; Wątroba, M | 1 |
| Gong, Z; Jiao, F | 1 |
| Auezova, L; Greige-Gerges, H; Latruffe, N; Lizard, G; Mackrill, JJ; Nury, T; Samadi, M; Vejux, A; Vervandier-Fasseur, D; Yammine, A; Zarrouk, A | 1 |
| Huang, J; Huang, N; Jin, F; Jin, H; Li, Y; Luo, Y; Shi, J; Xu, S; Yu, C | 1 |
| Gonmanee, T; Phruksaniyom, C; Ruangsawasdi, N; Songsaad, A; Thonabulsombat, C | 1 |
| Fukutomi, R; Isemura, M; Koyama, Y; Nakamura, Y; Ohishi, T; Pervin, M | 1 |
| Griñán-Ferré, C; Izquierdo, V; Pallàs, M; Palomera-Ávalos, V | 1 |
| Hu, S; Mao, Y; Wang, J; Wang, R; Xie, J; Zhao, X | 1 |
| Abrams, SL; Candido, S; Cervello, M; Cocco, L; Gizak, A; Lertpiriyapong, K; Libra, M; Martelli, AM; McCubrey, JA; Montalto, G; Rakus, D; Ratti, S; Steelman, LS | 1 |
| Asensio, VJ; Esteban, S; Miralles, A; Moranta, D; Sarubbo, F | 1 |
| Li, S; Li, YR; Lin, CC | 1 |
| Chiou, YS; Ho, CT; Lee, PS; Pan, MH | 1 |
| Cai, M; Cai, Z; Gu, X; Liu, D; Liu, K; Ma, Q; Tan, J; Zhang, Q | 1 |
| Bonafede, R; Mariotti, R; Parrella, E; Pizzi, M; Scambi, I; Schiaffino, L | 1 |
| Asemi, Z; Pourhanifeh, MH; Reiter, RJ; Shafabakhsh, R | 1 |
| Pallàs, M; Porquet, D; Sanfeliu, C; Vicente, A | 1 |
| Bao, L; Dong, H; Feng, X; Gao, Q; Gao, Y; Hao, J; Liang, N; Liu, H; Peng, L; Sun, J; Yu, X; Yue, Q; Zhang, J; Zhu, D | 1 |
| Alleaume-Butaux, A; Brugg, B; Deleglise, B; Hjorth, JJ; Lassus, B; Peyrin, JM; Schneider, B; Soubeyre, V; Vignes, M; Viovy, JL | 1 |
| Abdollahi, M; Saeidnia, S | 1 |
| Martinoli, MG; Renaud, J | 1 |
| Bigford, GE; Del Rossi, G | 1 |
| Chen, L; Le, W; Li, J; Song, L; Zhang, X | 1 |
| Hoseki, J; Maharjan, S; Oku, M; Sakai, Y; Tsuda, M | 1 |
| Anthony, NG; Gray, AI; Lim, KG; Mackay, SP; Pyne, NJ; Pyne, S | 1 |
| Aires, V; Delmas, D | 1 |
| Fuentes, JM; Gómez-Sánchez, R; González-Polo, RA; Pedro, JM; Pizarro-Estrella, E; Rodríguez-Arribas, M; Yakhine-Diop, SM | 1 |
| Ficarra, S; Galtieri, A; Giardina, B; Russo, A; Tellone, E | 1 |
| Miller, MG; Poulose, SM; Shukitt-Hale, B; Thangthaeng, N | 1 |
| Beiroa, D; Diaz-Ruiz, C; Labandeira-Garcia, JL; Rodriguez-Pallares, J; Rodriguez-Perez, AI | 1 |
| Nasr, M | 1 |
| Calvello, R; Cianciulli, A; Panaro, MA; Porro, C | 1 |
| Gyengesi, E; Münch, G; Sharman, MJ; Sonego, S; Venigalla, M | 1 |
| Daglia, M; de Oliveira, MR; Hajheydari, Z; Manayi, A; Nabavi, SF; Nabavi, SM | 1 |
| Bai, X; Ma, X; Xu, X; Yao, L | 1 |
| Dong, W; Wang, R | 1 |
| Weiskirchen, R; Weiskirchen, S | 1 |
| Kawano, H; Li, D; Li, HP; Liu, N; Tong, L; Yan, HJ; Zhao, L | 1 |
| Borges, PA; da Silva Barros, RG; de Oliveira, MR; de Rossi, FT; Jardim, FR; Nascimento, MX; Prescilio, IC | 1 |
| Ambriz-Tututi, M; Granados-Soto, V; Rocha-González, HI | 1 |
| Knutson, MD; Leeuwenburgh, C | 1 |
| Bajer, M; Bezbradica, S; Buzek, F; Dingermann, T; Renz, H; Schröder, K; Song, M; Zündorf, I | 1 |
| Camins, A; Casadesús, G; Coto-Montes, A; Pallàs, M; Pelegri, C; Smith, MA; Vilaplana, J | 1 |
| Simonyi, A; Sun, AY; Sun, GY; Wang, Q | 1 |
| Beas-Zarate, C; Camins, A; Folch, J; Junyent, F; Pallas, M; Sureda, FX; Verdaguer, E | 1 |
| Chen, YC; Chiou, SH; Hsieh, WL; Hung, CW; Kao, CL | 1 |
| Iglésias, ML; Mérillon, JM; Monti, JP; Pawlus, AD; Pedrot, E; Richard, T; Waffo-Teguo, P | 1 |
| Huber, K; Superti-Furga, G | 1 |
| Bramanti, P; Ciurleo, R; Foti Cuzzola, V; Giacoppo, S; Marino, S | 1 |
| Fu, YC; Wang, W; Yu, W | 1 |
| Abalo, R; Desco, M; Herradón, E; López-Miranda, V; Soto-Montenegro, ML; Vera, G | 1 |
| Burdan, F; Fraczek, M; Podlodowska, J; Szumiło, J | 1 |
| Donmez, G | 1 |
| Chavis, JA; Deel, MW; Drew, PD; Eubanks, AG; Hensley, LL; Stroope, BL; Tull, CA; Wight, RD | 1 |
| Maag, JL; Musgrave, IF; Smid, SD | 1 |
| Li, G; Yu, X | 1 |
| Doré, S | 1 |
| Ramassamy, C | 1 |
| Auwerx, J; Lagouge, M; Rasouri, S | 1 |
| Simonyi, A; Sun, AY; Sun, GY | 1 |
53 review(s) available for resveratrol and Neurodegenerative Diseases
| Article | Year |
|---|---|
Resveratrol-based compounds and neurodegeneration: Recent insight in multitarget therapy.
Topics: Humans; Neurodegenerative Diseases; Polyphenols; Resveratrol; Stilbenes; Structure-Activity Relationship | 2022 |
Is resveratrol a prospective therapeutic strategy in the co-association of glucose metabolism disorders and neurodegenerative diseases?
Topics: Alzheimer Disease; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Humans; Neurodegenerative Diseases; Resveratrol | 2022 |
Curcumin, Resveratrol and Cannabidiol as Natural Key Prototypes in Drug Design for Neuroprotective Agents.
Topics: Cannabidiol; Curcumin; Drug Design; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Resveratrol | 2022 |
Neuroprotective Effects of Resveratrol in In vivo and In vitro Experimental Models of Parkinson's Disease: a Systematic Review.
Topics: Humans; Models, Theoretical; Neurodegenerative Diseases; Neuroprotective Agents; Parkinson Disease; Resveratrol | 2022 |
Multifaceted role of polyphenols in the treatment and management of neurodegenerative diseases.
Topics: Berberine; Curcumin; Genistein; Humans; Luteolin; Neurodegenerative Diseases; Nitrogen; Oxygen; Polyphenols; Quercetin; Resveratrol; Synthetic Drugs | 2022 |
The Antioxidative Effects of Picein and Its Neuroprotective Potential: A Review of the Literature.
Topics: alpha-Synuclein; Animals; Antioxidants; Curcumin; Glucosides; Neurodegenerative Diseases; Neuroprotective Agents; Panax; Resveratrol; tau Proteins; Withania | 2022 |
Resveratrol-Mediated Regulation of Mitochondria Biogenesis-associated Pathways in Neurodegenerative Diseases: Molecular Insights and Potential Therapeutic Applications.
Topics: Antioxidants; Humans; Mitochondria; Neurodegenerative Diseases; Neurons; Organelle Biogenesis; Resveratrol | 2023 |
Therapeutic potential of natural molecules against Alzheimer's disease via SIRT1 modulation.
Topics: Alzheimer Disease; Humans; Memory Disorders; Neurodegenerative Diseases; Resveratrol; Sirtuin 1 | 2023 |
Nature's toolbox against tau aggregation: An updated review of current research.
Topics: Alzheimer Disease; Humans; Neurodegenerative Diseases; Resveratrol; tau Proteins | 2023 |
Polyphenols as Caloric-Restriction Mimetics and Autophagy Inducers in Aging Research.
Topics: Aging; Animals; Apoptosis; Autophagy; Caloric Restriction; Cellular Senescence; Diabetes Mellitus; Dietary Supplements; Healthy Aging; Humans; Longevity; Mitochondria; Neoplasms; Neurodegenerative Diseases; Polyphenols; Protein Aggregation, Pathological; Resveratrol; Sirtuin 1 | 2020 |
Review of beneficial effects of resveratrol in neurodegenerative diseases such as Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Antioxidants; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Resveratrol | 2020 |
The Beneficial Roles of SIRT1 in Neuroinflammation-Related Diseases.
Topics: Animals; Brain Injuries, Traumatic; Humans; NAD; Neurodegenerative Diseases; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Resveratrol; Sirtuin 1; Toll-Like Receptors | 2020 |
Signaling mechanisms underlying inhibition of neuroinflammation by resveratrol in neurodegenerative diseases.
Topics: Alzheimer Disease; Animals; Antioxidants; Humans; Inflammation; Macrophages; Mice; Microglia; Neurodegenerative Diseases; Neurons; Parkinson Disease; Rats; Resveratrol; Signal Transduction | 2021 |
Beneficial Effects of Epigallocatechin-3-
Topics: Animals; Antineoplastic Agents; Antioxidants; Catechin; Chlorogenic Acid; Curcumin; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Resveratrol | 2021 |
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases.
Topics: Berberine; Cardiovascular Diseases; Curcumin; Gene Expression Regulation; Glycogen Synthase Kinase 3; Humans; Inflammation; Mechanistic Target of Rapamycin Complex 1; Neoplasms; Neurodegenerative Diseases; Osteoarthritis; Phosphatidylinositol 3-Kinases; Protective Agents; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Resveratrol; Signal Transduction; Stilbenes | 2017 |
Effects of Resveratrol and Other Polyphenols on the Most Common Brain Age-Related Diseases.
Topics: Age Factors; Animals; Brain; Humans; Molecular Structure; Neurodegenerative Diseases; Polyphenols; Resveratrol; Stilbenes | 2017 |
Effect of resveratrol and pterostilbene on aging and longevity.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Cardiovascular Diseases; Cataract; Cellular Senescence; Humans; Inflammation; Longevity; Neoplasms; Neurodegenerative Diseases; NF-E2-Related Factor 2; Osteoporosis; Oxidative Stress; Resveratrol; Sirtuin 1; Stilbenes; Telomere Homeostasis | 2018 |
Chemoprevention by resveratrol and pterostilbene: Targeting on epigenetic regulation.
Topics: Anti-Inflammatory Agents; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Bone Diseases; Cardiovascular Diseases; Chemoprevention; DNA Methylation; Epigenesis, Genetic; Histones; Humans; MicroRNAs; Neoplasms; Neurodegenerative Diseases; Protein Processing, Post-Translational; Resveratrol; Stilbenes | 2018 |
The Effect of Resveratrol on Neurodegenerative Disorders: Possible Protective Actions Against Autophagy, Apoptosis, Inflammation and Oxidative Stress.
Topics: Animals; Apoptosis; Autophagy; Humans; Inflammation; Neurodegenerative Diseases; Oxidative Stress; Resveratrol | 2019 |
Resveratrol: new avenues for a natural compound in neuroprotection.
Topics: Aging; Animals; Antioxidants; Autophagy; Biological Products; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Resveratrol; Sirtuin 1; Stilbenes | 2013 |
Toxicological and pharmacological concerns on oxidative stress and related diseases.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Benzopyrans; Carbazoles; Carvedilol; Diabetes Mellitus; Disease Models, Animal; Ethanolamines; Humans; Hydrogen Peroxide; Inflammatory Bowel Diseases; Nebivolol; Neoplasms; Neurodegenerative Diseases; Osteoporosis; Oxidative Stress; Propanolamines; Reactive Oxygen Species; Resveratrol; Stilbenes; Vascular Diseases | 2013 |
Resveratrol as a protective molecule for neuroinflammation: a review of mechanisms.
Topics: Animals; Humans; Inflammation; Models, Biological; Neurodegenerative Diseases; Neuroprotective Agents; Resveratrol; Stilbenes | 2014 |
Supplemental substances derived from foods as adjunctive therapeutic agents for treatment of neurodegenerative diseases and disorders.
Topics: Acetylcarnitine; Alzheimer Disease; Brain; Brain Injuries; Cinnamates; Cognition Disorders; Curcumin; Depsides; Diet; Dietary Supplements; Fatty Acids, Omega-3; Humans; Neurodegenerative Diseases; Oxidative Stress; Polyphenols; Resveratrol; Rosmarinic Acid; Stilbenes | 2014 |
Resveratrol and its oligomers: modulation of sphingolipid metabolism and signaling in disease.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Binding Sites; Cardiovascular Diseases; Drug Discovery; Humans; Molecular Docking Simulation; Molecular Structure; Neoplasms; Neurodegenerative Diseases; Resveratrol; Signal Transduction; Sphingolipids; Stilbenes | 2014 |
Common pathways in health benefit properties of RSV in cardiovascular diseases, cancers and degenerative pathologies.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Humans; Neoplasms; Neurodegenerative Diseases; Polyphenols; Resveratrol; Signal Transduction; Stilbenes; Wine | 2015 |
Is the Modulation of Autophagy the Future in the Treatment of Neurodegenerative Diseases?
Topics: Animals; Autophagy; Disease Models, Animal; Food; Humans; Isothiocyanates; Lithium; Neurodegenerative Diseases; Resveratrol; Sirolimus; Spermidine; Stilbenes; Sulfoxides; Trehalose; Valproic Acid | 2015 |
Resveratrol: A Focus on Several Neurodegenerative Diseases.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Humans; Huntington Disease; Mitochondria; Neurodegenerative Diseases; Oxidative Stress; Parkinson Disease; Resveratrol; Stilbenes | 2015 |
Effects of pterostilbene and resveratrol on brain and behavior.
Topics: Aging; Animals; Antioxidants; Blood-Brain Barrier; Brain; Cognition Disorders; Humans; Neurodegenerative Diseases; Resveratrol; Social Behavior Disorders; Stilbenes; Treatment Outcome | 2015 |
Reviewing the Role of Resveratrol as a Natural Modulator of Microglial Activities.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Humans; Inflammation; Microglia; Neurodegenerative Diseases; Neuroprotective Agents; Resveratrol; Stilbenes | 2015 |
Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Antioxidants; Biological Products; Chronic Disease; Curcumin; Fish Oils; Humans; Inflammation; Neurodegenerative Diseases; Neurofibrillary Tangles; Neuroprotective Agents; Randomized Controlled Trials as Topic; Resveratrol; Stilbenes | 2016 |
Resveratrol and the mitochondria: From triggering the intrinsic apoptotic pathway to inducing mitochondrial biogenesis, a mechanistic view.
Topics: Animals; Apoptosis; Humans; Mitochondria; Neoplasms; Neurodegenerative Diseases; Resveratrol; Stilbenes | 2016 |
Small Molecules as SIRT Modulators.
Topics: Humans; Imidazoles; Naphthalenes; Neoplasms; Neurodegenerative Diseases; Polyphenols; Pyrimidinones; Resveratrol; Sirtuins; Small Molecule Libraries; Stilbenes; Triterpenes | 2018 |
[Effects of resveratrol-induced cellular autophagy in control of neurodegenerative diseases].
Topics: Alzheimer Disease; Autophagy; Humans; Huntington Disease; Neurodegenerative Diseases; Parkinson Disease; Resveratrol; Stilbenes | 2016 |
Resveratrol: How Much Wine Do You Have to Drink to Stay Healthy?
Topics: Coronary Disease; Diet; Dietary Supplements; Fruit; Glycosides; Humans; Inflammation; Metabolic Diseases; Neurodegenerative Diseases; Phytotherapy; Plant Extracts; Polyphenols; Resveratrol; Stilbenes; Wine | 2016 |
Resveratrol and Brain Mitochondria: a Review.
Topics: Aging; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Antioxidants; Brain; Humans; Mitochondria; Neoplasms; Neurodegenerative Diseases; Resveratrol | 2018 |
Resveratrol: a natural compound with pharmacological potential in neurodegenerative diseases.
Topics: Animals; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Pain; Phytoalexins; Resveratrol; Sesquiterpenes; Stilbenes; Terpenes | 2008 |
Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases.
Topics: Aging; Animals; Biological Availability; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Enzyme Activation; Enzyme Activators; Humans; Inflammation; Neurodegenerative Diseases; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes | 2008 |
Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection.
Topics: Animals; Humans; Models, Biological; Neurodegenerative Diseases; Neuroprotective Agents; Resveratrol; Signal Transduction; Sirtuins; Stilbenes | 2009 |
Resveratrol as a therapeutic agent for neurodegenerative diseases.
Topics: Alcohol-Induced Disorders, Nervous System; Animals; Antioxidants; Cell Death; Humans; Inflammation; Neurodegenerative Diseases; Neuroglia; Neurons; Oxidative Stress; Reactive Nitrogen Species; Reactive Oxygen Species; Resveratrol; Stilbenes; Stroke | 2010 |
An overview of investigational antiapoptotic drugs with potential application for the treatment of neurodegenerative disorders.
Topics: Animals; Apoptosis; Drug Design; Drugs, Investigational; Humans; Melatonin; Mitochondria; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Resveratrol; Stilbenes | 2010 |
Ageing and neurodegenerative diseases.
Topics: Aging; Antioxidants; Humans; Longevity; Neurodegenerative Diseases; Resveratrol; Stilbenes | 2010 |
Neuroprotective properties of resveratrol and derivatives.
Topics: Alzheimer Disease; Animals; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Resveratrol; Stilbenes | 2011 |
After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders.
Topics: Alzheimer Disease; Enzyme Inhibitors; Epigenesis, Genetic; Humans; Neurodegenerative Diseases; Parkinson Disease; Resveratrol; Sirtuins; Stilbenes; Up-Regulation | 2011 |
Role of resveratrol and its analogues in the treatment of neurodegenerative diseases: focus on recent discoveries.
Topics: Animals; Brain; Drug Discovery; Humans; Neurodegenerative Diseases; Neurons; Resveratrol; Signal Transduction; Stilbenes; Treatment Outcome | 2011 |
Cellular and molecular effects of resveratrol in health and disease.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Neurodegenerative Diseases; Platelet Aggregation Inhibitors; Resveratrol; Stilbenes | 2012 |
[Resveratrol: a neuroprotective polyphenol in the Mediterranean diet].
Topics: Amyloid beta-Peptides; Animals; Antioxidants; Biological Availability; Cardiotonic Agents; Cell Survival; Cerebrovascular Disorders; Diet, Mediterranean; DNA Repair; Humans; Nerve Tissue Proteins; Neurodegenerative Diseases; Neuroprotective Agents; Peripheral Nervous System Diseases; Reperfusion Injury; Resveratrol; Sirtuin 1; Spinal Cord; Stilbenes; Trauma, Nervous System; Vitis; Wine | 2012 |
[Resveratrol--phytophenol with wide activity].
Topics: Adipose Tissue; Animals; Anti-Inflammatory Agents; Atherosclerosis; Cardiovascular Diseases; Chemoprevention; Glucose; Humans; Longevity; Neoplasms; Neurodegenerative Diseases; Resveratrol; Stilbenes | 2012 |
The neurobiology of sirtuins and their role in neurodegeneration.
Topics: Aging; Animals; Drug Discovery; Humans; Inflammation; Neurodegenerative Diseases; Resveratrol; Sirtuins; Stilbenes; Stress, Physiological; Yeasts | 2012 |
Dietary polyphenol-derived protection against neurotoxic β-amyloid protein: from molecular to clinical.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Catechin; Cell Line; Curcumin; Diet; Humans; Models, Molecular; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Plants; Polyphenols; Resveratrol; Stilbenes; Tea | 2012 |
Unique properties of polyphenol stilbenes in the brain: more than direct antioxidant actions; gene/protein regulatory activity.
Topics: Animals; Antioxidants; Cerebrovascular Disorders; Encephalitis; Flavonoids; Gene Expression Regulation, Enzymologic; Heme Oxygenase (Decyclizing); Humans; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Phenols; Polyphenols; Resveratrol; Stilbenes | 2005 |
Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets.
Topics: Alzheimer Disease; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Blueberry Plants; Clinical Trials as Topic; Cognition; Curcumin; Flavonoids; Ginkgo biloba; Humans; Neurodegenerative Diseases; Parkinson Disease; Phenols; Plant Extracts; Polyphenols; Proteasome Endopeptidase Complex; Resveratrol; Signal Transduction; Stilbenes; Tea; Wine | 2006 |
[SIRT1/PGC-1: a neuroprotective axis?].
Topics: Acetylation; Amyloid beta-Peptides; Animals; Cells, Cultured; Humans; Mice; Mice, Knockout; Mice, Transgenic; Mitochondria; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Protein Processing, Post-Translational; Reactive Oxygen Species; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes; Transcription Factors; Transcriptional Activation | 2007 |
The "French Paradox" and beyond: neuroprotective effects of polyphenols.
Topics: Antioxidants; Coronary Disease; Flavonoids; France; Free Radicals; Humans; Neurodegenerative Diseases; Neurons; Oxidative Stress; Phenols; Polymers; Polyphenols; Resveratrol; Stilbenes; Vitis | 2002 |
24 other study(ies) available for resveratrol and Neurodegenerative Diseases
| Article | Year |
|---|---|
Alkylated resveratrol prodrugs and metabolites as potential therapeutics for neurodegenerative diseases.
Topics: Alkylation; Animals; Cell Survival; Cytokines; Dose-Response Relationship, Drug; Humans; Inflammation; Mice; Mice, Inbred C57BL; Molecular Structure; Neurodegenerative Diseases; Neurons; Nitro Compounds; Prodrugs; Propionates; RAW 264.7 Cells; Structure-Activity Relationship; Tumor Cells, Cultured; Zebrafish | 2018 |
p62/SQSTM1, a Central but Unexploited Target: Advances in Its Physiological/Pathogenic Functions and Small Molecular Modulators.
Topics: Animals; Atherosclerosis; Autophagy; Humans; Neurodegenerative Diseases; Osteitis Deformans; Protein Domains; Sequestosome-1 Protein; Signal Transduction; Tumor Suppressor Proteins | 2020 |
The involvement of TRPM2 on the MPP
Topics: 1-Methyl-4-phenylpyridinium; Animals; Animals, Newborn; Apoptosis; Hippocampus; Mice; Neurodegenerative Diseases; Neurons; Oxidative Stress; Reactive Oxygen Species; Resveratrol; TRPM Cation Channels | 2022 |
Toxicity studies of trans-resveratrol administered by gavage for two weeks or three months to F344/NTac rats, Wistar Han [Crl:WI(Han)] rats, and B6C3F1/N mice.
Topics: Animals; Carcinogenicity Tests; Mice; Mice, Inbred Strains; Neurodegenerative Diseases; Rats; Rats, Inbred F344; Rats, Wistar; Resveratrol | 2021 |
Protective effect of pterostilbene in a streptozotocin-induced mouse model of Alzheimer's disease by targeting monoamine oxidase B.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Animals; bcl-2-Associated X Protein; Caspase 3; Disease Models, Animal; Humans; Inflammation; Interleukin-6; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Neurodegenerative Diseases; NF-kappa B; Reactive Oxygen Species; Resveratrol; Stilbenes; Streptozocin; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2022 |
Resveratrol, Endocrine Disrupting Chemicals, Neurodegenerative Diseases and Depression: Genes, Transcription Factors, microRNAs, and Sponges Involved.
Topics: Amyotrophic Lateral Sclerosis; Brain-Derived Neurotrophic Factor; Cyclooxygenase 2; Depression; Endocrine Disruptors; Humans; Interleukin-6; MicroRNAs; Neurodegenerative Diseases; Parkinson Disease; Resveratrol; Transcription Factors | 2023 |
Resveratrol Analogues as Dual Inhibitors of Monoamine Oxidase B and Carbonic Anhydrase VII: A New Multi-Target Combination for Neurodegenerative Diseases?
Topics: Carbonic Anhydrases; Humans; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurodegenerative Diseases; Resveratrol; Structure-Activity Relationship | 2022 |
The inhibitory effect and mechanism of small molecules on acetic anhydride-induced BSA acetylation and aggregation.
Topics: Acetic Anhydrides; Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Amyloidogenic Proteins; Apigenin; Gallic Acid; Humans; Molecular Docking Simulation; Neurodegenerative Diseases; Protein Aggregates; Protein Processing, Post-Translational; Quercetin; Resveratrol; Vitamin K 3 | 2023 |
Prevention by Dietary Polyphenols (Resveratrol, Quercetin, Apigenin) Against 7-Ketocholesterol-Induced Oxiapoptophagy in Neuronal N2a Cells: Potential Interest for the Treatment of Neurodegenerative and Age-Related Diseases.
Topics: Animals; Apigenin; Apoptosis; Autophagy; Cell Line; Dose-Response Relationship, Drug; Humans; Ketocholesterols; Mice; Mitochondria; Neurodegenerative Diseases; Neurons; Oxidative Stress; Peroxisomes; Polyphenols; Quercetin; Reactive Oxygen Species; Resveratrol | 2020 |
Potential of resveratrol in enrichment of neural progenitor-like cell induction of human stem cells from apical papilla.
Topics: Cell Differentiation; Humans; Mesenchymal Stem Cells; Neural Stem Cells; Neurodegenerative Diseases; Resveratrol | 2020 |
Resveratrol Supplementation Attenuates Cognitive and Molecular Alterations under Maternal High-Fat Diet Intake: Epigenetic Inheritance over Generations.
Topics: Adenosine; Animals; Body Weight; Brain; Cognition; Diet, High-Fat; Dietary Supplements; DNA Methylation; Epigenesis, Genetic; Epigenomics; Female; Inflammation; Leptin; Male; Maternal Exposure; Maze Learning; Methylation; Mice; Neurodegenerative Diseases; Neuronal Plasticity; Obesity; Pregnancy; Pregnancy, Animal; Prenatal Exposure Delayed Effects; Resveratrol; Triglycerides | 2021 |
Neuroprotective effect of resveratrol on rotenone-treated C57BL/6 mice.
Topics: Animals; Disease Models, Animal; Dopaminergic Neurons; Insecticides; Iron; Male; Mice; Mice, Inbred C57BL; Neurodegenerative Diseases; Neuroprotective Agents; Psychomotor Disorders; Random Allocation; Resveratrol; Rotarod Performance Test; Rotenone; Stilbenes; Substantia Nigra; Tyrosine 3-Monooxygenase | 2017 |
AMPK/SIRT1/p38 MAPK signaling pathway regulates alcohol‑induced neurodegeneration by resveratrol.
Topics: AMP-Activated Protein Kinases; Animals; Ethanol; Gene Expression Regulation; Humans; Male; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Rats; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes | 2018 |
Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model.
Topics: Acetylation; Amyotrophic Lateral Sclerosis; Animals; Biomarkers; Disease Models, Animal; Epigenesis, Genetic; Histones; Mice; Motor Neurons; Neurodegenerative Diseases; Neuroprotective Agents; Prognosis; Resveratrol; Signal Transduction; Spinal Cord; Superoxide Dismutase; Transcription Factor RelA; Treatment Outcome | 2018 |
Resveratrol inhibits β-amyloid-induced neuronal apoptosis through regulation of SIRT1-ROCK1 signaling pathway.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Apoptosis; Calcium; Cell Survival; Flow Cytometry; Gene Expression Regulation; Homeostasis; L-Lactate Dehydrogenase; Neurodegenerative Diseases; Neurons; PC12 Cells; Peptide Fragments; Rats; Resveratrol; rho-Associated Kinases; Signal Transduction; Sirtuin 1; Stilbenes; Tetrazolium Salts; Thiazoles | 2013 |
Synapto-protective drugs evaluation in reconstructed neuronal network.
Topics: Amides; Amino Acid Chloromethyl Ketones; Animals; Axons; Dendrites; Embryo, Mammalian; Enzyme Inhibitors; Mice; Microfluidics; Microscopy, Fluorescence; Models, Neurological; NAD; Nerve Net; Neurodegenerative Diseases; Primary Cell Culture; Pyridines; Resveratrol; Stilbenes; Synapses | 2013 |
Resveratrol ameliorates motor neuron degeneration and improves survival in SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Antioxidants; Apoptosis; Behavior, Animal; Disease Models, Animal; Female; Lipid Peroxidation; Lumbar Vertebrae; Male; Mice; Mice, Transgenic; Microscopy, Fluorescence; Motor Neurons; Muscle, Skeletal; Neurodegenerative Diseases; Oxidative Stress; Resveratrol; Spinal Cord; Stilbenes; Superoxide Dismutase; Superoxide Dismutase-1; Tumor Suppressor Protein p53 | 2014 |
Mitochondrial impairment triggers cytosolic oxidative stress and cell death following proteasome inhibition.
Topics: Animals; Antioxidants; Apoptosis; Boronic Acids; Bortezomib; CHO Cells; Cricetinae; Cricetulus; Membrane Potential, Mitochondrial; Mitochondria; Neurodegenerative Diseases; Oxidative Stress; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proteolysis; Pyrazines; Reactive Oxygen Species; Resveratrol; Stilbenes; Ubiquitination | 2014 |
Reciprocal regulation between sirtuin-1 and angiotensin-II in the substantia nigra: implications for aging and neurodegeneration.
Topics: Aging; Angiotensin II; Animals; Brain; Cell Line; Dopaminergic Neurons; Gene Expression Regulation; Homozygote; Humans; Immunohistochemistry; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microscopy, Fluorescence; NADPH Oxidases; Neurodegenerative Diseases; Neuroglia; Neurons; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Resveratrol; Sirtuin 1; Stilbenes; Substantia Nigra | 2015 |
Development of an optimized hyaluronic acid-based lipidic nanoemulsion co-encapsulating two polyphenols for nose to brain delivery.
Topics: Administration, Intranasal; Animals; Brain; Curcumin; Emulsions; Hyaluronic Acid; Lipids; Nanoparticles; Nasal Mucosa; Neurodegenerative Diseases; Polyphenols; Rats; Resveratrol; Sheep; Stilbenes | 2016 |
Protective effect of resveratrol against nigrostriatal pathway injury in striatum via JNK pathway.
Topics: Animals; Apoptosis; Brain Injuries, Traumatic; Corpus Striatum; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Male; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mice; Neural Pathways; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Random Allocation; Resveratrol; Stilbenes; Substantia Nigra | 2017 |
[Red red wine].
Topics: Antioxidants; Cardiovascular Diseases; Humans; Neurodegenerative Diseases; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes; Wine | 2009 |
Resveratrol effects on astrocyte function: relevance to neurodegenerative diseases.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Astrocytes; C-Reactive Protein; Cells, Cultured; Chemokine CCL2; Cytokines; Interleukin-12 Subunit p40; Interleukin-23; Lipopolysaccharides; Mice; Neurodegenerative Diseases; Nitric Oxide; Resveratrol; Stilbenes | 2012 |
Effects of resveratrol on longevity, cognitive ability and aging-related histological markers in the annual fish Nothobranchius guentheri.
Topics: Aging; Animals; Anti-Inflammatory Agents, Non-Steroidal; beta-Galactosidase; Body Size; Cognition; Drug Evaluation, Preclinical; Female; Fishes; Lipofuscin; Longevity; Male; Maze Learning; Models, Animal; Motor Activity; Neurodegenerative Diseases; Neuroprotective Agents; Resveratrol; Stilbenes | 2012 |